---
title: "Single cell epigenomic profiling identifies a distinct classical monocyte subset driving inflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME)"
tags:
- âž• 2025-12-25
- ðŸ§ª Biomarker
created: '2025-11-20'
published: '2025-11-20'
---

<details>
<summary>Iu et al. (2025)</summary>

- **Authors:** David S. Iu, Faraz Ahmed, Elizabeth Fogarty, Carl Franconi, Jennifer Grenier, Maureen Hanson, Andrew Grimson
- **Institutes:** Cornell University, Ithaca, NY, USA
- **Publisher:** The Journal of Immunology
- **Link:** [DOI](https://doi.org/10.1093/jimmun/vkaf283.2434)

</details>

## Summary

This research identifies a specific subpopulation of immune cells that appears to be a primary driver of inflammation in ME/CFS. By pinpointing exactly which cells are 'reprogrammed' at the epigenetic level, the study provides a concrete target for future diagnostic tests and treatments aimed at stopping the inflammatory response that causes symptoms like post-exertional malaise.

## What was researched?

The study investigated how the gene regulatory landscape and chromatin accessibility of immune cells are reshaped in ME/CFS patients, particularly during post-exertional malaise (PEM).

## Why was it researched?

While previous studies identified general immune dysregulation in ME/CFS, it remained unclear which specific cell subsets were responsible for driving inflammation and how their internal 'genetic switches' were altered during symptom flares.

## How was it researched?

Researchers generated single-cell chromatin accessibility profiles (scATAC-seq) and transcriptomic data from peripheral blood mononuclear cells (PBMCs) of patients and healthy controls. These samples were collected both at baseline and after an exercise-induced PEM provocation to capture changes in real-time.

## What has been found?

The researchers identified a unique subpopulation of classical monocytes characterized by reduced CD14 accessibility and increased accessibility near pro-inflammatory genes. These specific genes were found to be significantly upregulated in ME/CFS patients. Additionally, the study observed widespread epigenetic reprogramming at transcription factor binding sites, particularly involving the NF-kappa-B (NF-ÎºB) family in monocytes.

## Discussion

The findings suggest that ME/CFS is characterized by a persistent state of monocyte activation that is etched into the cells' epigenome. This epigenetic 'priming' likely explains why patients react so strongly to physical exertion.

## Conclusion & Future Work

The discovery of a distinct, inflammatory monocyte subset provides a new biomarker for ME/CFS pathology. Future research should focus on whether these epigenetic changes can be reversed to alleviate systemic inflammation.

